Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Revenues $ 0 $ 0
Costs and Expenses    
Operating expenses 214,000 532,000
Research and development expenses 47,000 70,000
Loss from operations (261,000) (602,000)
Other expense    
Interest and financing expense (110,000) (164,000)
Net loss $ (371,000) $ (766,000)
Net loss per common share, basic and diluted $ (0.00) $ (0.00)
Weighted average common shares outstanding, basic and diluted 323,167,576 311,063,681